Blocking glycolysis — the molecular mechanism that makes it possible to extract energy from glucose — is especially damaging to the division of cancer cells, research shows. Specifically acting on this energy-based peculiarity could be effective in treating cancer in combination with chemotherapeutic agents such as taxol, scientists say.